For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Alkermes Controlled Therapeutics, Inc.

USPTO Granted Patents = 46

% Expired Patents = 28.3

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 2,768

Loading Chart...

Loading Chart...

39 inventors (with patents filed for the assignee):

Mark A Tracy (19 out of 23 patents)

Howard Bernstein (14 out of 67 patents)

M Amin Khan (12 out of 15 patents)

4. Paul F Herbert (8 out of 12 patents)

5. Warren E Jaworowicz (7 out of 8 patents)

6. Michael S Healy (6 out of 7 patents)

7. OluFunmi Lily Johnson (6 out of 10 patents)

8. M Gary I Riley (5 out of 7 patents)

9. Paul A Burke (5 out of 12 patents)

10. Henry R Costantino (4 out of 91 patents)

11. Yan Zhang (4 out of 8 patents)

12. Kevin L Ward (4 out of 10 patents)

13. J Michael Ramstack (4 out of 44 patents)

14. Stephen E Zale (4 out of 50 patents)

15. Henry E Auer (4 out of 8 patents)

Core Competencies:

Injectable Suspensions

Sustained Release

Microparticles

Biocompatible Polymers

Targeted Delivery

Oligonucleotides

Protein Microspheres

Controlled Release Devices

Modification of Release Profiles

Biologically Active Agents

Metal Cation Stabilization

Solid-Phase Particles

46 patents: Sort by Forward Citations

1. 7799345 - Preparation of injectable suspensions having improved injectability (2010-09-21),

2. 7658998 - Method of preparing sustained release microparticles (2010-02-09),

3. 7371406 - Preparation of injectable suspensions having improved injectability (2008-05-13),

4. 7282216 - Biocompatible polymer blends and uses thereof (2007-10-16),

5. 7097857 - Methods and compositions for the targeted delivery of biologically active agents (2006-08-29),

6. 7089681 - Method and apparatus for filtering and drying a product (2006-08-15),

7. 7074432 - Method of modifying the release profile of sustained release compositions (2006-07-11),

8. 7037450 - Production scale method of forming microparticles (2006-05-02),

9. 6780434 - Controlled release of metal cation-stabilized interferon (2004-08-24),

10. 6749866 - Modulated release from biocompatible polymers (2004-06-15),

11. 6726860 - Production scale method of forming microparticles (2004-04-27),

12. 6713087 - Method of producing submicron particles of a labile agent and use thereof (2004-03-30),

13. 6667061 - Preparation of injectable suspensions having improved injectability (2003-12-23),

14. 6569458 - Process for producing small particles of biologically active molecules (2003-05-27),

15. 6565888 - Methods and compositions for the targeted delivery of biologically active agents (2003-05-20),

Alkermes Controlled Therapeutics, Inc., based in Cambridge, MA, specializes in the development and manufacturing of innovative drug delivery systems. The company focuses on advanced technologies such as injectable suspensions, sustained release microparticles, and biocompatible polymer blends. Their expertise extends to targeted delivery and controlled release mechanisms, utilizing microencapsulation and submicron particles to enhance the efficacy of biologically active agents. Alkermes is committed to improving patient outcomes through its cutting-edge therapeutic solutions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

46 Patents

#59 in Cambridge, MA

#425 in Massachusetts

#7,590 in US

#15,096 in the World

Cambridge, MA, United States of America

Alkermes Controlled Therapeutics, Inc.

Forward Citations = 2,768

39 inventors:

Mark A Tracy (19 out of 23 patents)

Howard Bernstein (14 out of 67 patents)

M Amin Khan (12 out of 15 patents)

4. Paul F Herbert (8 out of 12 patents)

5. Warren E Jaworowicz (7 out of 8 patents)

Please report any incorrect information to [email protected]

Loading…